Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Pichler

Showing results (71-80 of 323) with videos related to

Pageof 33
Sort By:
Oncotarget|April 11, 2017
Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinomaCristina- Sorina Cătană, Martin Pichler, Gianluigi Giannelli, et al.
Anticancer Research|October 28, 2015
Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and FutureMichael Stotz, Armin Gerger, Johannes Haybaeck, et al.
Non-Coding RNA|July 10, 2020
Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in CancerDominik A Barth, Felix Prinz, Julia Teppan, et al.
Non-Coding RNA|September 30, 2020
Involvement of Long Non-Coding RNAs (lncRNAs) in Tumor AngiogenesisJulia Teppan, Dominik A Barth, Felix Prinz, et al.
Frontiers in Immunology|November 22, 2021
Emerging Role of Non-Coding RNAs in Regulation of T-Lymphocyte FunctionMohammad Taheri, Dominik A Barth, Julia Kargl, et al.
Cancers|April 3, 2019
Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?Renate Pichler, Eva Compérat, Tobias Klatte, et al.
In Vivo (Athens, Greece)|November 4, 2020
Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer PatientsJennifer Moritz, Thomas Bauernhofer, Sebastian Mannweiler, et al.
International Journal of Molecular Sciences|September 13, 2017
MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive ReviewMaria Anna Smolle, Andreas Leithner, Florian Posch, et al.
Histopathology|September 11, 2012
Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinomaMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
Current Pharmaceutical Biotechnology|May 25, 2011
Current status of therapeutic targeting of developmental signalling pathways in oncologyTobias Kiesslich, Frieder Berr, Beate Alinger, et al.
Pageof 33

Showing results (71-80 of 323) with videos related to

Sort By:
Pageof 33
Oncotarget|April 11, 2017
Non-coding RNAs, the Trojan horse in two-way communication between tumor and stroma in colorectal and hepatocellular carcinomaCristina- Sorina Cătană, Martin Pichler, Gianluigi Giannelli, et al.
Anticancer Research|October 28, 2015
Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and FutureMichael Stotz, Armin Gerger, Johannes Haybaeck, et al.
Non-Coding RNA|July 10, 2020
Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in CancerDominik A Barth, Felix Prinz, Julia Teppan, et al.
Non-Coding RNA|September 30, 2020
Involvement of Long Non-Coding RNAs (lncRNAs) in Tumor AngiogenesisJulia Teppan, Dominik A Barth, Felix Prinz, et al.
Frontiers in Immunology|November 22, 2021
Emerging Role of Non-Coding RNAs in Regulation of T-Lymphocyte FunctionMohammad Taheri, Dominik A Barth, Julia Kargl, et al.
Cancers|April 3, 2019
Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?Renate Pichler, Eva Compérat, Tobias Klatte, et al.
In Vivo (Athens, Greece)|November 4, 2020
Evaluation of Blood-based Biomarkers for Prediction of Response in Carboplatin-treated Metastatic Castration-resistant Prostate Cancer PatientsJennifer Moritz, Thomas Bauernhofer, Sebastian Mannweiler, et al.
International Journal of Molecular Sciences|September 13, 2017
MicroRNAs in Different Histologies of Soft Tissue Sarcoma: A Comprehensive ReviewMaria Anna Smolle, Andreas Leithner, Florian Posch, et al.
Histopathology|September 11, 2012
Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinomaMartin Pichler, Georg C Hutterer, Thomas F Chromecki, et al.
Current Pharmaceutical Biotechnology|May 25, 2011
Current status of therapeutic targeting of developmental signalling pathways in oncologyTobias Kiesslich, Frieder Berr, Beate Alinger, et al.
Pageof 33